WC
VTYX

Wexford Capital’s Ventyx Biosciences VTYX Stock Holding History

Wexford Capital’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-279,231
Closed -$321K – 329
2025
Q1 		$321K Sell
279,231
-119,232
-30% -$205K 0.08% 153
2024
Q4 		$873K Sell
398,463
-50,583
-11% -$115K 0.14% 72
2024
Q3 		$979K Hold
449,046
– – 0.23% 70
2024
Q2 		$1.04M Buy
449,046
+419,046
+1,397% +$1.74M 0.26% 61
2024
Q1 		$165K Buy
+30,000
New +$137K 0.03% 204

Other funds holding VTYX

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Wexford Capital's VTYX Position: Q2 2025 in Review

Wexford Capital sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 279,231 shares — an estimated $321K sold.

Wexford Capital first reported a position in VTYX in Q1 2024 and held it in 5 quarters. The position peaked at $1.04M in Q2 2024. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

  • Wexford Capital reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
  • Wexford Capital sold 279,231 Ventyx Biosciences shares in Q2 2025, an estimated $321K.
  • Wexford Capital first reported a position in Ventyx Biosciences in Q1 2024 and held it in 5 quarters.
  • Wexford Capital's Ventyx Biosciences position peaked at $1.04M in Q2 2024.
  • 114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on Wexford Capital's 13F filing for Q2 2025, filed 14 Aug 2025.